tert-Butyl (2R,5S)-2-ethyl-5-methylpiperazine-1-carboxylate, 98%, 100mg

5-(4-Fluorophenyl)oxazol-2-ylamine, 1g

Ethyl 3-[4-(benzyloxy)phenyl]-3-oxopropanoate, 95%, 1g

Iodopentafluorobenzene (stabilised with Copper), 99.0%, 10g

1-(3-Chloro-4-fluorobenzoyl)piperidin-4-one, 97%, 100mg

(2,6-Dimethylphenyl)acetic acid, 95.0%, 100mg

4-Methyl-1,3,2-dioxathiolane 2-Oxide (mixture of isomers)>98.0%(GC)25g

Potassium periodate, min. 99.8%, pa, ACS, 25 g, plastic packaging.

8-Bromo-5-chloroquinoline, 95.0%, 5g

2-Chloro-3-(3,4-dimethoxyphenyl)-1-propene, 97.0%, 1g

1,3,5-Tris(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzene, 97%, 1g

(2S,5S)-1-tert-Butyl 2-methyl 5-hydroxypiperidine-1,2-dicarboxylate, 95.0%, 1g

2-Amino-6-bromo-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one, 97%, 250mg